HPV Detection Kit

This kit is suitable for in vitro qualitative detection of 18 types of human papilloma viruses (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) specific nucleic acid fragments in female cervical exfoliated cells and HPV 16/18 typing, to help diagnose and treat HPV infections.

Epidemiology

Cervical cancer is one of the most common malignant tumors in the female reproductive tract. Studies have shown that persistent infection and multiple infections of human papillomavirus are one of the important causes of cervical cancer.

Reproductive tract HPV infection is common among women with sexual life. According to statistics, 70% to 80% of women may have HPV infection for once at least in their lifetime, but most infections are self-limiting, and more than 90% of infected women will develop an effective immune response that could clear the infection between 6 and 24 months without any long-term health intervention. Persistent high-risk HPV infection is the main cause of cervical intraepithelial neoplasia and cervical cancer.

The worldwide study results showed that the presences of high-risk HPV DNA were detected in 99.7% of cervical cancer patients. Therefore, the early detection and prevention of cervical HPV are the key to blocking canceration. The establishment of a simple, specific and rapid pathogenic diagnostic method is of great significance in the clinical diagnosis of cervical cancer.

Technical Parameters

Storage - ≤-18℃ in dark
Shelf-life - 12 months
Specimen Type - Cervical exfoliated cells
Ct - ≤28
CV - ≤5.0％
LoD - 25 Copies/reaction